Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.36
-0.14 (-0.90%)
Sep 11, 2026, 4:08 PM HKT

Sinopharm Group Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31,04548,79654,31363,80955,22243,529
Short-Term Investments
-2,7583,1723,3303,1992,812
Trading Asset Securities
0.080.130.160.550.511.75
Cash & Short-Term Investments
31,04551,55457,48667,13958,42146,353
Cash Growth
-11.90%-10.32%-14.38%14.92%26.04%-12.29%
Accounts Receivable
237,537206,652201,479185,790171,204172,576
Other Receivables
-4,9385,2484,0073,7033,698
Receivables
237,537211,589206,727189,797174,908176,273
Inventory
66,64063,34162,35360,02860,92651,500
Restricted Cash
-1,3541,3281,8501,488-
Other Current Assets
26,04918,95719,55418,02223,66516,796
Total Current Assets
361,271346,796347,448336,835319,406290,922
Property, Plant & Equipment
17,61518,22919,63219,89819,64719,408
Long-Term Investments
11,54611,31010,89410,5519,8409,184
Goodwill
-5,7846,2527,1867,1567,199
Other Intangible Assets
7,9862,2492,4732,8302,9413,116
Long-Term Accounts Receivable
95.91896.71,156793.921,123874.58
Long-Term Deferred Tax Assets
3,0652,8492,4081,9641,9801,787
Long-Term Deferred Charges
-142.29224.01180.0274.4476.61
Other Long-Term Assets
2,8482,1062,3443,1582,6072,845
Total Assets
404,427390,361392,831383,395364,775335,412

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
150,736150,248151,109146,632137,085128,431
Accrued Expenses
23,0147,5478,1238,8329,5718,354
Current Portion of Long-Term Debt
73,43963,32162,72954,73052,99755,152
Current Portion of Leases
1,3231,4991,7611,7971,6361,548
Current Income Taxes Payable
1,0891,4121,4471,7751,7031,614
Current Unearned Revenue
6,1345,9846,8296,39910,3966,086
Other Current Liabilities
2,41016,71418,37721,32621,57418,122
Total Current Liabilities
258,145246,726250,376241,491234,963219,307
Long-Term Debt
4,2153,6458,63713,83411,7508,419
Long-Term Leases
2,3392,4953,2593,4213,2073,250
Long-Term Unearned Revenue
77.91417.32413.86448.24493.85462.74
Pension & Post-Retirement Benefits
368.45364.9412.88366.51380.71387.7
Long-Term Deferred Tax Liabilities
561.98565.22638.75788.38936.741,023
Other Long-Term Liabilities
2,3801,9882,4062,7272,9752,910
Total Liabilities
268,087256,201266,144263,076254,706235,758

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3,1213,1213,1213,1213,1213,121
Additional Paid-In Capital
-24,64124,64124,64124,64124,641
Retained Earnings
60,03160,56555,53251,19744,70138,516
Treasury Stock
-3.84-3.84-3.84-3.84-3.84-3.84
Comprehensive Income & Other
22,047-4,370-4,407-4,373-4,391-4,388
Total Common Equity
85,19483,95378,88474,58268,06961,886
Minority Interest
51,14550,20647,80445,73742,00137,768
Shareholders' Equity
136,339134,160126,687120,319110,06999,654
Total Liabilities & Equity
404,427390,361392,831383,395364,775335,412

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
81,31670,96076,38673,78269,59068,368
Net Cash (Debt)
-50,271-19,407-18,900-6,643-11,169-22,016
Net Cash Growth
------
Net Cash Per Share
-16.11-6.22-6.06-2.13-3.58-7.05
Filing Date Shares Outstanding
3,1213,1213,1213,1213,1213,121
Total Common Shares Outstanding
3,1213,1213,1213,1213,1213,121
Working Capital
103,126100,07097,07295,34484,44371,616
Book Value Per Share
27.3026.9025.2823.9021.8119.83
Tangible Book Value
77,20875,92170,15964,56657,97251,571
Tangible Book Value Per Share
24.7424.3322.4820.6918.5816.53
Buildings
-14,23413,75212,99712,90712,127
Machinery
-11,19810,72810,0999,1698,412
Construction In Progress
-842.34739.81505.47800.05718.53